WHWK

WHITEHAWK THERAPEUTICS, INC.

Company Overview

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

SectorHealthcare
IndustryBiotechnology
Market Cap$262.2M
Employees32
CEODavid J. Lennon

Valuation

Current Price$4.6
Fair Value?$000.00
Valuation?No valuation
Hist. PE ?N/A
EPS (TTM) ?-0.96
Forward EPS Growth ?
Historical Growth ?58.88%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro

Price

EPS

Revenue

Equity

Pro

Available on the Pro plan

Free Cash Flow

Pro

Available on the Pro plan

Long Term Debt

Pro

Available on the Pro plan

Net Profit

Pro

Available on the Pro plan

Shares Outstanding

Pro

Available on the Pro plan

Last updated: 9/5/2026, 7:02:04 PM